GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhytoHealth Corp (TPE:4108) » Definitions » Piotroski F-Score

PhytoHealth (TPE:4108) Piotroski F-Score : 4 (As of Apr. 06, 2025)


View and export this data going back to 2008. Start your Free Trial

What is PhytoHealth Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PhytoHealth has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for PhytoHealth's Piotroski F-Score or its related term are showing as below:

TPE:4108' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 6
Current: 4

During the past 13 years, the highest Piotroski F-Score of PhytoHealth was 6. The lowest was 3. And the median was 4.


PhytoHealth Piotroski F-Score Historical Data

The historical data trend for PhytoHealth's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhytoHealth Piotroski F-Score Chart

PhytoHealth Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 4.00 3.00 5.00 4.00

PhytoHealth Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 5.00 4.00

Competitive Comparison of PhytoHealth's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, PhytoHealth's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhytoHealth's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhytoHealth's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PhytoHealth's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was -27.964 + -15.86 + -11.076 + -18.601 = NT$-73.5 Mil.
Cash Flow from Operations was -20.217 + -22.57 + -4.807 + -2.54 = NT$-50.1 Mil.
Revenue was 32.588 + 44.125 + 39.817 + 37.032 = NT$153.6 Mil.
Gross Profit was 9.458 + 20.703 + 15.585 + 18.261 = NT$64.0 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(2350.511 + 2373.989 + 2344.258 + 2461.783 + 2439.67) / 5 = NT$2394.0422 Mil.
Total Assets at the begining of this year (Dec23) was NT$2,350.5 Mil.
Long-Term Debt & Capital Lease Obligation was NT$11.9 Mil.
Total Current Assets was NT$1,306.4 Mil.
Total Current Liabilities was NT$54.4 Mil.
Net Income was -7.428 + -15.062 + 7.29 + -31.917 = NT$-47.1 Mil.

Revenue was 32.962 + 39.408 + 43.515 + 46.604 = NT$162.5 Mil.
Gross Profit was 13.175 + 16.415 + 18.684 + 19.369 = NT$67.6 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(2364.628 + 2343.609 + 2386.533 + 2345.707 + 2350.511) / 5 = NT$2358.1976 Mil.
Total Assets at the begining of last year (Dec22) was NT$2,364.6 Mil.
Long-Term Debt & Capital Lease Obligation was NT$17.5 Mil.
Total Current Assets was NT$1,499.5 Mil.
Total Current Liabilities was NT$57.4 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PhytoHealth's current Net Income (TTM) was -73.5. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PhytoHealth's current Cash Flow from Operations (TTM) was -50.1. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-73.501/2350.511
=-0.03127022

ROA (Last Year)=Net Income/Total Assets (Dec22)
=-47.117/2364.628
=-0.01992576

PhytoHealth's return on assets of this year was -0.03127022. PhytoHealth's return on assets of last year was -0.01992576. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PhytoHealth's current Net Income (TTM) was -73.5. PhytoHealth's current Cash Flow from Operations (TTM) was -50.1. ==> -50.1 > -73.5 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=11.883/2394.0422
=0.00496357

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=17.46/2358.1976
=0.00740396

PhytoHealth's gearing of this year was 0.00496357. PhytoHealth's gearing of last year was 0.00740396. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=1306.393/54.396
=24.01634311

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=1499.456/57.378
=26.13294294

PhytoHealth's current ratio of this year was 24.01634311. PhytoHealth's current ratio of last year was 26.13294294. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PhytoHealth's number of shares in issue this year was 198.619. PhytoHealth's number of shares in issue last year was 198.619. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=64.007/153.562
=0.41681536

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=67.643/162.489
=0.4162928

PhytoHealth's gross margin of this year was 0.41681536. PhytoHealth's gross margin of last year was 0.4162928. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=153.562/2350.511
=0.06533133

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=162.489/2364.628
=0.06871652

PhytoHealth's asset turnover of this year was 0.06533133. PhytoHealth's asset turnover of last year was 0.06871652. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PhytoHealth has an F-score of 4 indicating the company's financial situation is typical for a stable company.

PhytoHealth  (TPE:4108) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PhytoHealth Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of PhytoHealth's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


PhytoHealth Business Description

Traded in Other Exchanges
N/A
Address
No. 167 Fuxing North Road, 1st Floor, 5th Floor, Taipei, TWN, 104
PhytoHealth Corp is a botanical drug development company. It engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. Its products include PG2 Lyo. Injection 500mg, PhytoHealth EnerCharge Capsule, NatoCleanse, ReyeasCleanse, and PhytoHealth EnerCharge Drink.

PhytoHealth Headlines

No Headlines